CANY
KOD icon

Caxton Associates (New York)’s Kodiak Sciences KOD Stock Holding History

Caxton Associates (New York)’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-46,213
Closed -$287K – 575
2023
Q1 		$287K Sell
46,213
-42,834
-48% -$300K 0.04% 361
2022
Q4 		$638K Buy
89,047
+31,386
+54% +$225K 0.04% 195
2022
Q3 		$446K Sell
57,661
-51,137
-47% -$497K 0.06% 265
2022
Q2 		$831K Buy
+108,798
New +$764K 0.08% 159
2020
Q2 		– Sell
-4,637
Closed -$221K – 553
2020
Q1 		$221K Buy
+4,637
New +$278K 0.04% 329

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Caxton Associates (New York)'s KOD Position: Q2 2023 in Review

Caxton Associates (New York) sold out of Kodiak Sciences (KOD) in Q2 2023, closing a stake of 46,213 shares — an estimated $287K sold.

Caxton Associates (New York) first reported a position in KOD in Q1 2020 and held it in 5 quarters. The position peaked at $831K in Q2 2022. 128 funds tracked by Wall St. Rank hold KOD as of Q2 2023.

  • Caxton Associates (New York) reported no remaining Kodiak Sciences position as of Q2 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 46,213 Kodiak Sciences shares in Q2 2023, an estimated $287K.
  • Caxton Associates (New York) first reported a position in Kodiak Sciences in Q1 2020 and held it in 5 quarters.
  • Caxton Associates (New York)'s Kodiak Sciences position peaked at $831K in Q2 2022.
  • 128 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.